|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
|---|---|
| Information provided by: | National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
| ClinicalTrials.gov Identifier: | NCT00004551 |
Purpose
This study is to evaluate the effectiveness of a mood management intervention on abstinent alcoholic smokers with a history of major depression. The second aim is to determine the effect of smoking treatments on alcohol abstinence and to identify factors associated with smoking and alcohol outcomes (e.g., more days of abstinence). A randomized, two-group design will be used to evaluate the added benefit of mood management compared to a state-of-the-art smoking cessation treatment. Treatment will consist of 8 weekly group sessions and 1, 3, 6, and 12-month follow-up.
| Condition | Intervention | Phase |
|---|---|---|
|
Alcoholism Smoking |
Drug: nicotine replacement patch Behavioral: mood management |
Phase IV |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Open Label, Efficacy Study |
| Official Title: | Mood Management Training for Alcohol Dependent Smokers |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| United States, Minnesota | |
| Department of Internal Medicine, Mayo Foundation | |
| Rochester, Minnesota, United States, 55905 | |
| Principal Investigator: | Christ A. Patten, PhD | Mayo Clinic |
More Information
| Study ID Numbers: | NIAAAPAT11890 |
| Study First Received: | February 3, 2000 |
| Last Updated: | December 6, 2007 |
| ClinicalTrials.gov Identifier: | NCT00004551 History of Changes |
| Health Authority: | United States: Federal Government |
|
Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Cholinergic Agonists Nicotinic Agonists Physiological Effects of Drugs Disorders of Environmental Origin Cholinergic Agents Pharmacologic Actions |
Mental Disorders Nicotine Autonomic Agents Alcoholism Substance-Related Disorders Ganglionic Stimulants Alcohol-Related Disorders Peripheral Nervous System Agents |